Polymorphisms at the NACP-REP1 region regulate SNCA expression, and dinucleotide polymorphisms at the NACP-REP1 locus were associated with Parkinson’s and Alzheimer’s Diseases [30,31]. The gene discussed is CHM; the disease is Parkinsonism.